Literature DB >> 3618105

The nosological position of the ophthalmoplegia, ataxia and areflexia syndrome: "the spectrum hypothesis".

A S Najim Al-Din.   

Abstract

Two cases of ophthalmoplegia ataxia and areflexia are described, each with undoubted central and peripheral neural affection. It is concluded that the cardinal features are due to brainstem pathology, and support the hypothesis that this syndrome and the post-infectious polyradiculoneuritides represent differing ends of a spectrum which reflects two modes of nervous system reaction to a presumed infective challenge.

Entities:  

Mesh:

Year:  1987        PMID: 3618105     DOI: 10.1111/j.1600-0404.1987.tb05449.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

Review 1.  Localization of the pathological process in Miller Fisher syndrome.

Authors:  F Barontini; S Di Lollo; S Maurri; P Lambruschini
Journal:  Ital J Neurol Sci       Date:  1992-04

2.  Bickerstaff brainstem encephalitis. A case report.

Authors:  R M Camarda; R Cammalleri; D Raimondo
Journal:  Ital J Neurol Sci       Date:  1992-03

3.  Bilateral ptosis, ataxia and areflexia--a variant of Fisher's syndrome.

Authors:  P K Yip
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

4.  A brain-stem lesion in the Miller Fisher syndrome demonstrated by CT and MRI.

Authors:  M J Taphoorn; B M Uitdehaag; P Lanting
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

5.  Miller Fisher-Guillain-Barré overlap syndrome with enhancing lesions in the spinocerebellar tracts.

Authors:  M Urushitani; F Udaka; M Kameyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

6.  MR imaging findings of spinal posterior column involvement in a case of Miller Fisher syndrome.

Authors:  Nobuhiro Inoue; Homare Ichimura; Satoshi Goto; Yoichiro Hashimoto; Yukitaka Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.